Last reviewed · How we verify
NCT05491564
SoftStitch™ for All-Inside Meniscal Repair: Comparative Analysis of Patient Reported Outcome Measures
trial testing SoftStitch™ in Meniscus Tear in 50 participants. Status unknown.
1 October 2024
Quick facts
| Lead sponsor | Arthrex, Inc. |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 July 2023 |
| Primary completion | 1 October 2024 |
| Estimated completion | 1 October 2024 |
Drugs / interventions tested
- SoftStitch™
Conditions studied
- Meniscus Tear — all drugs for Meniscus Tear →
Sponsor
Arthrex, Inc. — full company profile →
Who can join
Adults 18 to 55, any sex, with Meniscus Tear. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Acute and traumatic knee meniscus tears are a frequent occurrence. Evidence shows meniscal repair results in more favorable patient reported outcomes and articular cartilage preservation.1 This prospective, multicenter, single cohort, longitudinal study is intended to evaluate the effectiveness and safety profile of SoftStitch™ when used as standard of care for All-Inside Meniscal Repair. Electronic Patient Reported Outcome Measures (ePROM), functional assessments of the knee, Adverse Events of interest and Adverse Device Effects will be assessed.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Research progress and clinical application of all-inside reconstruction techniques: narrative review.
Jiang Y, Qian D, Lu Q, Cao Y, et al · · 2025 · cited 1× · PMID 41019127 · DOI 10.3389/fsurg.2025.1644737
Verify or expand the search:
- PubMed search for NCT05491564
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Meniscus Tear
Currently open trials in the same condition.
- NCT07366619 — Magic Angle Direction Imaging (MADI) ACL Study · recruiting
- NCT06870825 — Assessment of Quadriceps Femoris Muscle Function in Patients After Arthroscopic Knee Surgery in Outpatient Rehabilitatio · NA · active not recruiting
- NCT06541756 — Fibrine Clot-augmented Repair of Longitudinal Meniscus Tears · NA · recruiting
- NCT06532851 — The Effect of Therapeutic Exercise on Cartilage Morphology and Physical Function for Individuals at High Risk of Knee Os · NA · recruiting
- NCT05266365 — The Video-Based Exercise Programs in Degenerative Meniscus Tears · NA · active not recruiting
Other Arthrex, Inc. trials
Trials by the same sponsor.
- NCT05765266 — ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial · NA · completed
- NCT05981833 — Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears · recruiting
- NCT05438914 — Subscapularis Repair in Reverse Shoulder Arthroplasty · NA · unknown
- NCT05314608 — Knee Related Subchondral Bone Lesions Treated With IOBP · recruiting
- NCT05046600 — Registry of Arthrex Hand and Wrist Products · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05491564 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Arthrex, Inc.
- Last refreshed: 2 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05491564.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing